Notify me when Propel Bio Management, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 20 | $117,123,993 | +$33,370,322 | -$27,973,472 | +$5,396,850 | PAGP, ACHV, PHAT, VRDN, MIST | 13F-HR | 11 Feb 2026, 10:09 |
| Q3 2025 | 16 | $99,894,525 | +$23,679,602 | -$14,128,877 | +$9,550,725 | PAGP, ACHV, AKRO, MIST, APLT | 13F-HR | 12 Nov 2025, 14:31 |
| Q2 2025 | 16 | $82,391,669 | +$12,835,452 | -$20,281,800 | -$7,446,348 | PAGP, ACHV, AKRO, PHAT, ABEO | 13F-HR | 13 Aug 2025, 11:29 |
| Q1 2025 | 18 | $86,073,350 | +$6,384,062 | -$17,698,729 | -$11,314,667 | PAGP, MDGL, AKRO, PHAT, ACHV | 13F-HR | 15 May 2025, 13:18 |
| Q4 2024 | 21 | $100,691,182 | +$4,883,005 | -$6,133,005 | -$1,250,000 | PAGP, MDGL, AKRO, ACHV, APLT | 13F-HR | 14 Feb 2025, 13:58 |
| Q3 2024 | 21 | $172,410,614 | +$4,199,440 | -$13,410,586 | -$9,211,146 | APLT, PAGP, PHAT, ACHV, TCRX | 13F-HR | 13 Nov 2024, 10:07 |
| Q2 2024 | 24 | $154,191,610 | +$39,592,664 | -$40,237,791 | -$645,127 | APLT, PAGP, TCRX, MDGL, ACHV | 13F-HR | 12 Aug 2024, 09:02 |
| Q1 2024 | 29 | $146,761,798 | +$33,558,492 | -$40,117,381 | -$6,558,889 | APLT, TCRX, MDGL, ACHV, PHAT | 13F-HR | 13 May 2024, 16:03 |
| Q4 2023 | 33 | $120,613,104 | $0 | $0 | $0 | PAGP, APLT, TCRX, MDGL, CRNX | 13F-HR | 14 Feb 2024, 16:12 |